Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology

Molecular Biology of the Cell

Volumn 4, Issue 1, 1993, Pages 121-133

  Goldman, Corey K ^a   Kim, Jin ^b   Wong, Wai Lee ^b   King, Vickie ^a   Brock, Tommy ^a   Gillespie, G Yancey ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027412319     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.4.1.121     Document Type: Article

References (30)

1. Adachi, K., Belser, P., Li, D., Rodeck, U., Bender, H., Benveniste, E.N., Woo, D., Schmiegel, W.H., and Herlyn, D. (1992). Enhancement of epidermal growth factor receptor (EGF-R) expression on glioma cells by recombinant tumor necrosis factor (rTNF)-α. Cancer Immunol. Immunother. 34, 370-376.
2. Bar, R.S., Boes, M., Boorth, B.A., Dake, B.L., Henley, S., and Hart, M.N. (1989). The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124, 1841-1848.
3. Bethea, J.R., Chung, I.Y., Sparacio, S.M., Gillespie, G.Y., and Benveniste, E.N. (1992a). Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells. J. Neuroimmunol. 36, 179-191.
4. Bethea, J.R., Gillespie, G.Y., and Benveniste, E.N. (1992b). Interleukin1β induction of TNF-α expression: involvement of protein kinase C. J. Cell. Physiol. 152, 264-273.
5. Bethea, J.R., Gillespie, G.Y., Chung, I.Y., and Benveniste, E.N. (1990). Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D-54MG. J. Neuroimmunol. 30, 1-13.
6. Bigner, D.D., Bigner, S.H., Ponten, J., Westermark, B., Mahaley, M.S., Ruoslahti, E., Berschman, H., Eng, L.G., and Wikstrand, C.J. (1981). Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40, 210-229.
7. Bigner, S.H., Bjerkvig, R., and Laerum, O.D. (1985). DNA content and chromosomal composition of malignant human gliomas. Neurol. Clin. 3, 769-784.
8. Bigner, S.H., and Mark, J. (1984). Chromosomes and chromosomal progression of human gliomas in vivo, in vitro and in athymic nude mice. Prog. Exp. Tumor Res. 27, 67-82.
9. Blumenstock, M., Prosenc, N., Patt, S., Pfanne, K., Drum, F., and Cervos-Navarro, J. (1991). In contrast to EGFR gene overexpression, H-ras gene expression decreases in human gliomas. Anticancer Res. 11, 1353-1358.
10. Bostrom, S., Holmgren, E., Jonsson, O., Lindberg, S., Lindstrom, B., Winso, I, and Zachrisson, B. (1987). Fibriopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients. Acta Neurochir. 88, 49-55.
11. Bostrom, S., Holmgren, E., Jonsson, O., Lindstrom, B., and Stigendal, L. (1986). Post-operative thromboembolism in neurosurgery. A study on the prohylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin. Acta Neurochir. 80, 83-89.
12. Brady, L.W., Miyamoto, C., Woo, D.V., Rackover, M., Emrich, J., Bender, H., Dadparvar, S., Steplewski, Z., Koprowski, H., Black, P., Lazzaro, B., Nair, S., McCormack, T., Nieves, J., Morabito, M., and Eishleman, J. (1991). Malignant astrocytomas treated with Iodine-125 labeled monoclonal antibody against epidermal growth factor receptor: A phase II trial. Int. J. Radiat. Oncol. Biol. Phys. 22, 225-230.
13. Brock, T.A., and Capasso, E.L. (1988). Thrombin and histamine activate phospholipase C in human endothelial cells via a phorbol ester-sensitive pathway. J. Cell. Physiol. 336, 54-62.
14. 2+ and von Willebrand Factor release in human endothelial cells. Am. J. Pathol. 138, 213-221.
15. Burger, P.C., and Green, S.B. (1987). Patient age, histologie features and length of survival in patients with glioblastoma multiforme. Cancer 57, 1617-1623.
16. Burger, P.C., and Kleihues, P. (1989). Cytologie composition of the untreated GBM with implications for evaluation of needle biopsies. Cancer 63, 2014-2023.
17. Chen, T. (1977). In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 204, 255-262.
18. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P.C., Pan, Y.C., Olander, J.V., Connolly, D.T., and Stern, D. (1990). Vascular permeability factor: a tumor derived polypepride that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535-1545.
19. Conn, G., Soderman, D.D., Schaeffer, M., Wile, M., Hatcher, V.B., and Thomas, K.A. (1990). Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Biochemistry 87, 1323-1327.
20. Connolly, D.T. (1991). Vascular Permeability Factor: A Unique Regulator of Blood Vessel Function. J. Cell. Biochem. 47, 219-223.
21. Constantini, S., Kornowski, R., Pomeranz, S., and Rappaport, Z.H. (1991). Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain rumors. Acta Neurochir. 109, 93-97.
22. Criscuolo, G.R., Lelkes, P.I., Rotrosen, D., and Oldfield, E.H. (1989). Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J. Neurosurg. 72, 884-891.
23. Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, J., and Leung, D.W. (1941). The Vascular Endothelial Growth Factor Family. J. Cell. Biochem. 47. 211-218.
24. Fett, J.W., Strydom, D.J., Lobb, R.R., Alderman, E.M., Bethune, J.L., Rordan, J.F., and Vallee, B.L. (1985). Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486.
25. Folkman, J. (1972). Anti angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 173, 409-416.
26. Fulling, K.H., and Nelson, D.F. (1984). Cerebral astrocytic neoplasmas in the adult: contribution of histologie examination to the assessment of prognosis. Semin. Diag. Pathol. 1, 152-163.
27. Gospodarowicz, D. (1989). Expression and control of vascular endothelial cells: proliferation and differentiation by fibroblast growth factors. J. Invest. Dermatol. 93, 39S-47S.
28. Tuomela, T. (1990). Epidermal growth factor concentrations in submandibular salivary gland, plasma, liver, bile, kidneys, and urine of: male mice: dynamics after phenylephrine injection. Life Sci. 46, 1197-1206.
29. Wikstrand, C.J., Grahmann, F.C., McComb, R.D., and Bigner, D.D. (1985). Antigenic heterogeneity of human anaplastic gliomas and glioma derived cell lines defined by monoclonal antibodies. J. Neuropathol. Exp. Neurol. 44, 229-241.
30. Zagzag, D., Miller, D.C., Sato, Y., Rifkin, D.B., and Burstein, D.E. (1990). Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res. 50, 7393-7398.